SCHEMBL6780065

SCHEMBL6780065

O=C(c1cc2ccccc2s1)N(Cc1ccccc1-c1ccccc1)c1cccnc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NPY2R P49146 3/20 0.42
▸ TBXAS1 P24557 1/20 0.42
▸ CLK1 P49759 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ BCL2L1 Q07817 1/20 0.40
▸ KCNA5 P22460 4/20 0.39
▸ DRD2 P14416 1/20 0.38
▸ DRD3 P35462 1/20 0.38
▸ CYP3A4 P08684 3/20 0.38
▸ KCNH2 Q12809 1/20 0.37
▸ PDK1 Q15118 1/20 0.37
▸ CYP11B1 P15538 1/20 0.37
▸ CYP11B2 P19099 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6779984 0.89 NPY2R (0.44) NPY2RTBXAS1BCL2L1PDK1ALDH1A1
SCHEMBL6779489 0.83 CLK1 (0.48) NPY2RTBXAS1CLK1L3MBTL1CYP11B1
SCHEMBL6784951 0.78 KMT2A (0.44) GAATSHRCYP3A4KDM4EALDH1A1
SCHEMBL6780403 0.76 TSHR (0.44) TBXAS1GAATSHRKCNA5CYP3A4
SCHEMBL6775285 0.73 GAA (0.46) TBXAS1GAATSHRKCNA5CYP3A4
SCHEMBL6780637 0.73 LMNA (0.46) GAATSHRKCNA5KCNH2PDK1
SCHEMBL6781088 0.72 ALDH1A1 (0.45) L3MBTL1GAATSHRKCNA5CYP3A4
SCHEMBL6779481 0.72 KCNA5 (0.50) KCNA5KCNH2
SCHEMBL4764550 0.69 LTB4R2 (0.47) GAATSHRPDK1ALDH1A1HTT
SCHEMBL24620830 0.66 DYRK1A (0.62) TBXAS1CLK1GAABCL2L1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US claimed
US-6780883-B2 ANTICHOLESTEROL AGENTS; CARDIOVASCULAR DISORDERS; ANTILIPEMIC AGENTS; RESTENOSIS; DIETETICS WARNER-LAMBERT COMPANY 2004-08-24 — — US disclosed
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein CETP, MTTP, LCAT NPY2R 4051/4885TBXAS1 457/4885CLK1 4666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback